RAD51D and ovarian cancer: Norquist et al. found that 3.3% of epithelial ovarian cancers also had other gene mutations (such as BRIP1, PALB2, RAD51C, RAD51D, and BARD1), which can increase the risk of ovarian cancer by 5%-15% [36].